Subjects taking both tirzepatide and other glucose-lowering medications should be monitored for hypoglycemia [21]
This first column reviews three drugs in development: tirzepatide (Mounjaro, Eli Lilly) for HF with preserved ejection fraction, ziltivekimab (Novo Nordisk) for inflammation in CVD and chronic kidney disease (CKD), and obicetrapib (NewAmsterdam Pharma) for hypercholesterolemia in high-risk patients
Tenderness at the injection area: The skin around the injection site may feel slightly sore or sensitive for a short time
Surgical resection is the primary treatment of MPNST, which is usually followed by a poor outcome
If changes in digestion or constipation make you uncomfortable, our team of healthcare professionals can help restore balance without affecting your progress
The NICE recommendations state that the benefits of the medicine are seen alongside diet and physical activity changes, but it does not state what this should look like, ie, is it brief advice or a referral to a support programme